Cargando…
Peri-cardiac surgery coagulation management in a severe hemophilia A patient: A case report
RATIONALE: Hemophilia A (HA) is an X-linked recessive disorder caused by clotting factor VIII (FVIII) deficiency. There is limited data on the use of replacement therapy in cardiac surgery. Since no international guideline for anticoagulation in such patient exists, careful thought should be taken t...
Autores principales: | Xu, Hongfei, Henry, Davies, Li, Chengcheng, Zhao, Haige, Yang, Yanyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587658/ https://www.ncbi.nlm.nih.gov/pubmed/31192923 http://dx.doi.org/10.1097/MD.0000000000015897 |
Ejemplares similares
-
Cardiac angiosarcoma: A case report and review of current treatment
por: Linfeng, Qian, et al.
Publicado: (2019) -
Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea
por: Moon, Byung Suk, et al.
Publicado: (2013) -
Updates on Coagulation Management in Cardiac Surgery
por: Najafi, Mahdi, et al.
Publicado: (2014) -
Coagulation Factor IX for Hemophilia B Therapy
por: Orlova, N. A., et al.
Publicado: (2012) -
Extended Half-Life Coagulation Factors: A New Era in the Management of Hemophilia Patients
por: Ar, Muhlis Cem, et al.
Publicado: (2019)